最新の財務諸表(Form-10K)によると、Fresenius SE & Co KGaAの総資産は$0で、純利益は$1,264です。
FSNUYの主要な財務比率は何ですか?
Fresenius SE & Co KGaAの流動比率は0、純利益率は5.52、1株当たり売上高は$40.53です。
Fresenius SE & Co KGaAの収益はセグメントまたは地域別にどのように分けられていますか?
Fresenius SE & Co KGaA の最大収益セグメントは Fresenius Kabi で、最新の利益発表における収益は 8,414,000,000 です。地域別に見ると、North America が Fresenius SE & Co KGaA の主要市場であり、収益は 2,701,000,000 です。
Fresenius SE & Co KGaAは収益を上げていますか?
はい、最新の財務諸表によると、Fresenius SE & Co KGaAの純利益は$1,264です。
Fresenius SE & Co KGaAに負債はありますか?
いいえ、Fresenius SE & Co KGaAの負債は0です。
Fresenius SE & Co KGaAの発行済株式数は何株ですか?
Fresenius SE & Co KGaAの総発行済株式数は0株です。
主要データ
前終値
$12.89
始値
$12.78
当日レンジ
$12.64 - $12.96
52週レンジ
$9.78 - $33.93
取引高
3.4K
平均取引高
63.0K
配当利回り
--
1株当たり利益(TTM)
0.61
時価総額
$7.2B
Fresenius SE & Co. KGaAとは何ですか?
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.